Rates of COVID-19 rebound were similar in patients who did and didn’t receive antiviral drugs, and relapse wasn’t tied to worse clinical outcomes.
COVID antivirals not tied to rebound or worse outcomes
More from COVID-19More posts in COVID-19 »
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients
- COVID-19 linked to increased preterm birth, other problems in pregnancy